SKI Market

A+| A| A-|

Indian Indices

Sensex

77,883.44 -633.05
( -0.81%)

Global Indices

Nasdaq

49,509.71 339.32
(0.69%)

Dow Jones

7,158.76 73.75
(1.04%)

Hang Seng

59,542.04 192.87
(0.32%)

Nikkei 225

10,480.54 -17.55
(-0.17%)

Forex

USD-INR

93.44 0.45
(0.48%)

EUR-INR

109.88 0.43
(0.39%)

GBP-INR

126.24 0.55
(0.44%)

JPY-INR

0.59 0.00
(0.27%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Dr Reddys Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500124

INE089A01031

377.5510998

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

DRREDDY

21.89

101577.75

EPS(TTM)

Face Value()

Div & Yield %

55.59

0.66

Back

Biogen Pharmachem Industries reports standalone net profit of Rs 0.46 crore in the December 2025 quarter

Feb 11,2026

Net profit of Biogen Pharmachem Industries reported to Rs 0.46 crore in the quarter ended December 2025 as against net loss of Rs 0.31 crore during the previous quarter ended December 2024. There were no Sales reported in the quarter ended December 2025 and during the previous quarter ended December 2024.

77,883.44 -633.05 ( -0.81%)

49,509.71 339.32 (0.69%)

7,158.76 73.75 (1.04%)

59,542.04 192.87 (0.32%)

10,480.54 -17.55 (-0.17%)

93.44 0.45 (0.48%)

109.88 0.43 (0.39%)

126.24 0.55 (0.44%)

0.59 0.00 (0.27%)